Advertisement

Topics

Microbix Announces Expanded Customer Supply Agreement / $25 Million of Expected Sales, With Approximately $10 Million of New Business

08:04 EDT 8 Aug 2017 | FinanzNachrichten

TORONTO, ONTARIO -- (Marketwired) -- 08/08/17 -- Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, announces the execution of an agreement to supply an exi...

Original Article: Microbix Announces Expanded Customer Supply Agreement / $25 Million of Expected Sales, With Approximately $10 Million of New Business

NEXT ARTICLE

More From BioPortfolio on "Microbix Announces Expanded Customer Supply Agreement / $25 Million of Expected Sales, With Approximately $10 Million of New Business"

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...